Adlai Nortye ANL
NASDAQ ANL
$15.01 +0.26 (+1.76%)
At close: Sep 4, 2026 · 4:00 PM EDT

Adlai Nortye (ANL) Common Equity (2022 - 2026)

Adlai Nortye (ANL) posted quarterly Common Equity of -$8.3 million for Q4 2025, down 132.65% year-over-year from $25.5 million in Q4 2024, and down 205.06% quarter-over-quarter from $7.9 million in Q2 2025.

Analysis

Adlai Nortye (ANL) Common Equity (2022 - 2026) Analysis & Trends

Adlai Nortye (ANL) has reported Common Equity for 4 consecutive years, with -$8.3 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Common Equity fell 132.65% year-over-year to -$8.3 million; the TTM figure through Dec 2025 stood at -$8.3 million (down 132.65% YoY), while the FY2025 annual figure was -$8.3 million, down 132.65% from the prior year.
  • Common Equity declined to -$8.3 million in Q4 2025 per ANL's latest filing, from $7.9 million in the prior quarter.
  • Across five years, Common Equity topped out at $75.0 million in Q4 2023 and bottomed at -$241.3 million in Q4 2022.
  • Historically, Common Equity has averaged -$24.3 million across 4 years, with a median of $1.8 million in 2024.
  • On a YoY basis, Common Equity climbed as much as 281.8% in 2025 and fell as far as 132.65% in 2025.
  • Adlai Nortye's Common Equity stood at -$241.3 million in 2022, then surged by 131.1% to $75.0 million in 2023, then plunged by 66.04% to $25.5 million in 2024, then slumped by 132.65% to -$8.3 million in 2025.
  • Business Quant data shows ANL's Common Equity at -$8.3 million in Q4 2025, $7.9 million in Q2 2025, and $25.5 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 20.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 31.71 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 8.42 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 6.76 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.61 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.17 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.35 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 9.79 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 757.49 Mn
10 Adlai Nortye 500.08 Mn 268.19 Mn - 214.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 214.83 Mn
Dec 31, 2025 -8.32 Mn
Jun 30, 2025 7.92 Mn
Dec 31, 2024 2,000.00
Jun 30, 2024 53.37 Mn
Dec 31, 2023 75.05 Mn
Dec 31, 2022 -241.29 Mn